跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEXPLANON - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NEXPLANON
Authorized
STANDARD
NEXPLANON
organon canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8ac5086bee701653
Company
organon canada inc.
Type
Standard
Approval Details
Approval Id
8ac5086bee701653
Drug Approval Canada Name
NEXPLANON
Product Name
NEXPLANON
Status
Marketed
Status Date
2022-09-08
Original Market Date
2020-08-17
Din
02499509
Drug Class
Human
Dosage Form
Implant
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
68:12.00
Atc Original
G03AC08 ETONOGESTREL
Atc Name
g 03 ac 08
Aig Number
0162274001
Company Name
organon canada inc.
Company Address
300, 16766 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7
Active Ingredients
ETONOGESTREL
68 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8ac5086bee701653
Type
Standard
Back to Health Canada Approvals